Zimmer Biomet Holdings, Inc.
ZBH
$105.73
$0.970.93%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.03% | 5.57% | -42.87% | 53.10% | 15.84% |
| Total Depreciation and Amortization | 11.76% | 6.62% | 9.29% | 4.02% | 2.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.73% | -30.95% | 64.57% | 55.06% | -21.70% |
| Change in Net Operating Assets | 52.41% | 65.21% | 2,545.45% | -56.88% | -7.50% |
| Cash from Operations | 2.38% | 67.89% | -13.95% | 17.21% | 6.18% |
| Capital Expenditure | -10.77% | 23.92% | 27.03% | 42.41% | 35.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,744.06% | -- | -56.86% | -- | -375.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.07% | 97.06% | -221.40% | -15.48% | -35.21% |
| Cash from Investing | -460.49% | 45.64% | -31.88% | 6.46% | -1.60% |
| Total Debt Issued | 388.89% | 2,397.29% | 47.32% | 503.45% | 169.23% |
| Total Debt Repaid | -- | -- | -178.69% | -150.00% | -- |
| Issuance of Common Stock | -93.94% | -70.39% | -97.41% | -10.14% | -73.71% |
| Repurchase of Common Stock | 91.62% | -102.29% | 82.40% | -- | -500.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.85% | 3.24% | 4.38% | 1.80% | 1.79% |
| Other Financing Activities | 76.83% | -261.48% | -44.00% | -525.00% | -67.35% |
| Cash from Financing | 278.24% | 1,248.50% | 4.30% | 48.01% | 16.00% |
| Foreign Exchange rate Adjustments | 542.42% | 222.81% | -344.59% | 377.78% | 43.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,142.65% | 3,867.54% | -135.28% | 639.49% | 361.54% |